324
Participants
Start Date
April 30, 2009
Primary Completion Date
September 30, 2011
Study Completion Date
May 31, 2015
Interferon β-1a
"Sterile preservative-free solution packaged in graduated pre-filled syringes~Subcutaneous injection~Ascending doses from 8.8 to 44 mcg according to local standard for Rebif®"
Teriflunomide
"Film-coated tablet~Oral administration"
Investigational Site Number 056003, Brussels
Investigational Site Number 348001, Budapest
Investigational Site Number 348005, Budapest
Investigational Site Number 348003, Budapest
Investigational Site Number 348002, Esztergom
Investigational Site Number 788002, Monastir
Investigational Site Number 348007, Kecskemét
Investigational Site Number 348004, Veszprém
Investigational Site Number 056001, Ghent
Investigational Site Number 756002, Sankt Gallen
Investigational Site Number 203003, Prague
Investigational Site Number 276011, Berlin
Investigational Site Number 380006, Torino
Investigational Site Number 300001, Athens
Investigational Site Number 276012, Berlin
Investigational Site Number 203002, Prague
Investigational Site Number 380007, Genova
Investigational Site Number 380001, Milan
Investigational Site Number 380004, Pavia
Investigational Site Number 724002, Majadahonda
Investigational Site Number 724003, Murcia
Investigational Site Number 276010, Hanover
Investigational Site Number 250003, Bordeaux
Investigational Site Number 250001, Montpellier
Investigational Site Number 276001, Bochum
Investigational Site Number 276006, Essen
Investigational Site Number 724001, Bilbao
Investigational Site Number 276002, Münster
Investigational Site Number 276009, Mainz
Investigational Site Number 203004, Jihlava
Investigational Site Number 250004, Lille
Investigational Site Number 380010, Ancona
Investigational Site Number 250005, Clermont-Ferrand
Investigational Site Number 276007, Erbach im Odenwald
Investigational Site Number 250002, Strasbourg
Investigational Site Number 380005, Bari
Investigational Site Number 380003, Cefalù
Investigational Site Number 276003, Bad Mergentheim
Investigational Site Number 056002, Hasselt
Investigational Site Number 124003, Lévis
Investigational Site Number 124002, London
Investigational Site Number 124004, St. John's
Investigational Site Number 276005, Dresden
Investigational Site Number 276004, Halle
Investigational Site Number 300002, Thessaloniki
Investigational Site Number 380008, Cagliari
Investigational Site Number 380002, Roma
Investigational Site Number 616002, Bialystok
Investigational Site Number 616004, Gdansk
Investigational Site Number 616003, Lublin
Investigational Site Number 616001, Warsaw
Investigational Site Number 724007, Barcelona
Investigational Site Number 826002, London
Investigational Site Number 826003, Plymouth
Lead Sponsor
Sanofi
INDUSTRY